EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
102 hedge funds and large institutions have $693M invested in Eidos Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 10 closing their positions.
Holders
102
Holders Change
+23
Holders Change %
+29.11%
% of All Funds
2.01%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
33
Increased
30
Reduced
27
Closed
10
Calls
$16.5M
Puts
$5.7M
Net Calls
+$10.8M
Net Calls Change
+$10.7M
Top Buyers
| 1 |
GGHC
1
Gilder Gagnon Howe & Co
New York
|
$21.2M |
| 2 |
2
Artisan Partners
Milwaukee,
Wisconsin
|
$19.4M |
| 3 |
DCM
3
Driehaus Capital Management
Chicago,
Illinois
|
$12.5M |
| 4 |
4
Holocene Advisors
New York
|
$9.62M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$23.1M |
